HCAT EBITDA Growth
Health Catalyst Inc · EBITDA Growth
HCAT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-460.54%period ending
HCAT TTM EBITDA YoY % (15.13% → -460.54%)
Year-over-year change
High-resolution chart · PNG
HCAT ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -460.5448% | |
| -1,267.8945% | |
| -460.3707% | |
| 3.2648% | |
| 4.1539% | |
| 74.9282% | |
| 73.2107% | |
| 53.3075% | |
| 60.5272% | |
| 40.2664% | |
| 20.739% | |
| 25.7054% | |
| 3.8944% | |
| 7.483% | |
| 18.1633% | |
| 3.5794% | |
| -11.3657% | |
| -20.24% | |
| -27.8567% | |
| -60.8472% | |
| -41.0399% | |
| -73.7731% | |
| -85.0948% | |
| -39.5241% | |
| -48.1464% | |
| 7.3455% | |
| 15.1256% |